Tenon Medical, Inc. Reports Third Quarter 2026 Financial Results
Tenon Medical, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $1.4 million and a net loss of $6.6 million.
Stocks · News reference
Maxim Group analyst Anthony Vendetti has maintained a "Buy" rating on Tenon Medical, Inc. while reducing the price target from $10 to $5.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Tenon Medical, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $1.4 million and a net loss of $6.6 million.
Tenon Medical, Inc. has scheduled the release of its financial results for the third quarter of 2026.
Tenon Medical has successfully completed the initial alpha cases for its new Quickstep Decorticator, a component of its next-generation SImmetry+ SI Joint Fusion System.
https://www.sec.gov/Archives/edgar/data/1560293/000121390026110252/ea0308890-424b5_tenon.htm
https://patentcenter.uspto.gov/applications/18793176/ifw/docs?application=